suggest that CD47 signaling in myeloid cells such as macrophages may have a protective role against atherosclerosis in vivo, and that systemic CD47 inhibition may reduce atherosclerosis by suppressing smooth muscle cell CD47 expression and stimulating efferocytosis. Here, CD47 is linked to atherosclerosis.